CN102018775A - Traditional Chinese medicine for treating prostatic hyperplasia - Google Patents
Traditional Chinese medicine for treating prostatic hyperplasia Download PDFInfo
- Publication number
- CN102018775A CN102018775A CN2010102321615A CN201010232161A CN102018775A CN 102018775 A CN102018775 A CN 102018775A CN 2010102321615 A CN2010102321615 A CN 2010102321615A CN 201010232161 A CN201010232161 A CN 201010232161A CN 102018775 A CN102018775 A CN 102018775A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- radix
- prostatic hyperplasia
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating prostatic hyperplasia, belonging to the field of traditional Chinese medicines for treating diseases of the urinary system. The traditional Chinese medicine aims to obtain good and fast effect. The traditional Chinese medicine is prepared from raw materials including radix semiaquilegiae, Angelica sinensis, glossy ganoderma, the root of red-rooted salvia, pseudo-ginseng and the like. The traditional Chinese medicine has the functions of strengthening the body resistance and cultivating the vitality, tonifying qi and nourishing blood, activating blood and eliminating blood stasis and diminishing swelling and dissipating stagnation and has the advantages of obvious effect, exact drug effect and fast effect taking.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of urinary system.
Background technology
The present Chinese medicine aspect that is used for the treatment of male prostatic hyperplasia, the deficiency that has two aspects: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of prostatic hyperplasia patients are because of can not get the treatment of active drug for a long time, frequent frequent micturition, urgent micturition, dysurea, unable, the urine retention of urine, urinary incontinence, protracted course of disease, symptoms such as very misery, and Chang Bingfa urine retention, hematuria, perineal position pain.Patient and family members thereof are very dissatisfied.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of prostatic hyperplasia, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, and the slower problem that takes effect is effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of prostatic hyperplasia adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Semiaquilegiae 5---12 parts of 40 parts of Radix Angelicae Sinensis 6---50 portions of Ganodermas 2---
20 parts of Radix Salviae Miltiorrhizaes 6---50 portions of Radix Notoginseng 3---
The Chinese medicine of this treatment prostatic hyperplasia is made by following method:
(1) by above-mentioned weight ratio, Radix Semiaquilegiae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with the extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Salviae Miltiorrhizae the body resistance strengthening and constitution consolidating in the side, benefiting QI and nourishing blood, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; Be aided with the Radix Semiaquilegiae heat-clearing and toxic substances removing, dispersing swelling and dissipating binds is used to alleviate the prostatic hyperplasia enlargement.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of dispersing swelling and dissipating binds, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Radix Semiaquilegiae 50 gram Radix Angelicae Sinensis 60 kairine sesames 20 grams
Radix Salviae Miltiorrhizae 60 gram Radix Notoginseng 30 grams
Weight in accordance with regulations, with conventional water extraction process Radix Semiaquilegiae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae are extracted, make extractum fine powder 51 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with the extractum fine powder, make fine particle, adorn capsule No. 0, make 360 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Radix Semiaquilegiae 200 gram Radix Angelicae Sinensis 260 kairine sesames 60 grams
Radix Salviae Miltiorrhizae 260 gram Radix Notoginseng 90 grams
By above-mentioned same method, make 1307 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Radix Semiaquilegiae 400 gram Radix Angelicae Sinensis 500 kairine sesames 120 grams
Radix Salviae Miltiorrhizae 500 gram Radix Notoginseng 200 grams
By above-mentioned same method, make 2642 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
2 parts of 7 portions of Ganodermas of 6 parts of Radix Angelicae Sinensis of Radix Semiaquilegiae
3 parts of 7 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
5 parts of 25 portions of Ganodermas of 20 parts of Radix Angelicae Sinensis of Radix Semiaquilegiae
9 parts of 25 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is example with the prostatic hyperplasia, through 7 routine clinical observations.Selecting the tcm diagnosis prostatic hyperplasia is standard: male's limb is soft weak, physical weakness, and it is not smooth to urinate---and frequent micturition, urgent micturition, dysurea, urine are unable, urine retention, urine are hesitated, urine retention.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, be the male all, there is not other serious disease, the age is 49 years old-81 years old, 71.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are obviously alleviated; Urine retention, urine are hesitated, urine retention obviously alleviates.
2, effective: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are alleviated to some extent; Urine is hesitated, urine retention alleviates to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 3 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 4 people, effective 2 people, invalid 1 people, total effective rate 85.7%.
Claims (1)
1. Chinese medicine for the treatment of prostatic hyperplasia is characterized in that making by comprising the following traditional Chinese medicines prescription: Radix Semiaquilegiae 5---and 40 parts, Radix Angelicae Sinensis 6---50 parts, Ganoderma 2---12 parts, Radix Salviae Miltiorrhizae 6---50 parts, Radix Notoginseng 3---20 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102321615A CN102018775A (en) | 2010-07-15 | 2010-07-15 | Traditional Chinese medicine for treating prostatic hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102321615A CN102018775A (en) | 2010-07-15 | 2010-07-15 | Traditional Chinese medicine for treating prostatic hyperplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102018775A true CN102018775A (en) | 2011-04-20 |
Family
ID=43860823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102321615A Pending CN102018775A (en) | 2010-07-15 | 2010-07-15 | Traditional Chinese medicine for treating prostatic hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102018775A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1457842A (en) * | 2003-06-02 | 2003-11-26 | 杨少林 | Cancer preventing and curing Chinese medicine of two snakes and Ganoderma Lucidum seu Japonicum |
| CN101406594A (en) * | 2007-10-10 | 2009-04-15 | 北京绿源求证科技发展有限责任公司 | Chinese medicine for treating tumor of lung |
-
2010
- 2010-07-15 CN CN2010102321615A patent/CN102018775A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1457842A (en) * | 2003-06-02 | 2003-11-26 | 杨少林 | Cancer preventing and curing Chinese medicine of two snakes and Ganoderma Lucidum seu Japonicum |
| CN101406594A (en) * | 2007-10-10 | 2009-04-15 | 北京绿源求证科技发展有限责任公司 | Chinese medicine for treating tumor of lung |
Non-Patent Citations (1)
| Title |
|---|
| 韦景春: "前列腺增生症中医药治疗概述", 《实用中医内科杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843787B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843699B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN102114172A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
| CN102068594A (en) | Chinese medicament for treating chronic prostatitis | |
| CN101843804A (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101972349A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN101843733B (en) | Chinese medicament for treating ichthyosis | |
| CN102068529A (en) | Traditional Chinese medicine for treatment of prostatic hyperplasia | |
| CN101843778B (en) | Chinese medicament for treating ichthyosis | |
| CN101843718B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101843739B (en) | Oral Chinese medicament for treating fracture | |
| CN101843803A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN101843759B (en) | Oral Chinese medicament for treating fracture | |
| CN101843734B (en) | Chinese medicament for treating abnormal menstruation | |
| CN101843693A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN102018760A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN102018775A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN102018856A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN101843771B (en) | Chinese medicament for treating ichthyosis | |
| CN101843750B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843711B (en) | Chinese medicament for treating ichthyosis | |
| CN101843816B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843808B (en) | Chinese medicament for treating ichthyosis | |
| CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110420 |